Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging

Published on September 6, 2018

Nathan Duval, Guido N. Vacano, David Patterson

Read Full Article (External Site)